Introductory Chapter: Overview on Nanomedicine Market

[1]  Young Hee Choi,et al.  Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics , 2017, Journal of Pharmaceutical Investigation.

[2]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[3]  Kinam Park.  The beginning of the end of the nanomedicine hype. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[4]  H. Devalapally,et al.  Role of nanotechnology in pharmaceutical product development. , 2007, Journal of pharmaceutical sciences.

[5]  A. Elaissari,et al.  Nanotechnology olymer-based nanocapsules for drug delivery , 2009 .

[6]  S. Mitragotri,et al.  Nanoparticles in the clinic , 2016, Bioengineering & translational medicine.

[7]  Samir Mitragotri,et al.  Nanoparticles in the clinic: An update , 2019, Bioengineering & translational medicine.

[8]  Koichi Wada,et al.  Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. , 2011, International journal of pharmaceutics.